NCT03295786View on ClinicalTrials.gov

Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 26, 2017

Primary Completion Date

December 19, 2019

Study Completion Date

December 19, 2019

Conditions
Parkinson DiseaseMovement DisordersNeurodegenerative DiseasesNervous System DiseasesBrain Diseases
Interventions
DRUG

Cerebral Dopamine Neurotrophic Factor

Repeated intracerebral infusions

DEVICE

Renishaw Drug Delivery System

Stereotactically implanted device

Trial Locations (3)

00029

Helsinki University Hospital, Helsinki

221 85

Skåne University Hospital, Lund

141 86

Karolinska University Hospital, Huddinge, Stockholm

Sponsors
All Listed Sponsors
collaborator

Renishaw plc.

UNKNOWN

lead

Herantis Pharma Plc.

INDUSTRY

NCT03295786 - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter